Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy
Artículo
![Thumbnail](/themes/Mirage2/images/cubierta.jpg)
Open/ Download
Publication date
2007Metadata
Show full item record
Cómo citar
López, Mercedes N.
Cómo citar
Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy
Author
Abstract
PURPOSE. Uveal melanoma is the most common primary malignant
ocular cancer in adults. This tumor has a distinct expression
pattern of markers compared with cutaneous melanoma.
MC1R is under study as a potential target for antitumor immunity.
Because of the potential immunogenicity of MC1R, it is
important to evaluate its expression on uveal melanomas.
METHODS. Two novel monoclonal antibodies (MP1.1C11 and
MP1.1B7) were used to examine the expression of MC1R in
uveal melanomas. Tissue samples obtained from 17 patients
were analyzed for expression of MC1R by immunohistochemistry.
Additionally, uveal melanoma cell lines were treated with
proinflammatory cytokines, after which MC1R cell surface expression
was analyzed by flow cytometry.
RESULTS. Results demonstrated that MC1R is expressed by uveal
melanoma to a significantly greater extent than other melanoma
markers. With the use of MP1.1C11 or MP1.1B7, MC1R
was detected in 95% of the tested melanoma tissues, including
one liver metastasis. In contrast, MART-1, S100-specific protein,
and gp-100 were only expressed by 66%, 33%, and 67% of
the analyzed samples, respectively. Results also demonstrated
that even though MC1R is mainly located intracellularly, its cell
surface expression can be promoted by cytokines such asIFN-gamma, TNF-alpha, IL-4, and IL-10.
CONCLUSIONS. These observations support the inclusion of MC1R in the panel of markers for the diagnosis of uveal melanoma. Therapeutic use of MC1R-specific antibodies targeting cytokine-induced MC1R potentially requires expression of the target molecule on the surfaces of tumor cells. Data presented here support MC1R as a new marker and a putative therapeutic target for uveal melanoma.
Indexation
Artículo de publicación SCOPUS
Identifier
URI: https://repositorio.uchile.cl/handle/2250/164209
DOI: 10.1167/iovs.06-0090
ISSN: 01460404
Quote Item
Investigative Ophthalmology and Visual Science, 2007;48:1219–1227
Collections